E-DRUG: Nominations now open for the 2021 Helen Clark-JoPPP Award in Pharmaceutical Policy and Practice
---------------------------------------------------------------------------
DEADLINE November 11.
https://joppp.biomedcentral.com/joppp-award
The Helen Clark-Journal of Pharmaceutical Policy and Practice (JoPPP) Award recognises the talents of exceptional individuals who are making a significant contribution to the field of pharmaceutical policy and practice.It is a yearly award started in 2018.
The announcement for this year's winners can be found here.. 2019's winners can be found here. ...
https://joppp.biomedcentral.com/joppp-award-winners-2019
Nominations are now open for the 2021 Helen Clark-JoPPP Award in Pharmaceutical Policy and Practice.
The Helen Clark-Journal of Pharmaceutical Policy and Practice (JoPPP) Award recognizes the talents of exceptional individuals, who are making a significant contribution to the field of pharmaceutical policy and practice. It is a yearly award started in 2018.
2020's winners can be found here <http://https//joppp.biomedcentral.com/joppp-award-winners-2020>\.
2018's winners can be found here
<https://joppp.biomedcentral.com/joppp-award-winners-2018>\.
About the award
[Helen Clark ONZ SSI PC]Helen Elizabeth Clark ONZ SSI PC is a New Zealand politician who served as the 37th Prime Minister of New Zealand from 1999 to 2008, and was the Administrator of the United Nations Development Programme from 2009 to 2017. This Award is named after her to acknowledge her significant contribution in the field of health and global development.
How to nominate
Candidates for the Award can be self-nominated or nominated by individuals. This includes a letter of support of 500 words or less outlining why the candidate meets the criteria for the Award. Written consent from the nominees for the Award must be obtained before submission of the nomination.
Selection criteria
Nominees must meet all three criteria listed below to be eligible for the Award. Nominations must include evidence that these criteria have been met consistently over 10 or more years.
1. Public health impact: Significant contributions to promote “policy and practice, pharmaceutical system strengthening, pharmaceutical health services research, access to and use of medicines”.
2. Capacity-building record: A distinguished record in teaching, training, consulting, practice, giving guidance to students (e.g. supervision of PhD students), research (capacity-building through collaboration across universities), health professionals (e.g. pharmacists) and policy-makers (e.g. policy advice) in the field of pharmaceutical policy and practice.
Award eligibility
Everyone can nominate and can be nominated for the award. You may nominate as many different persons as you like, but you can only self-nominate once. Unsuccessful nominees may be nominated for the award in subsequent years.
Selection process
Once nominations close on the 11th of November, the judges will determine the Award recipient from a shortlist of candidates solely based on the information provided in the nomination letter. The weighing for each of the two criteria is:
1. Public health impact - 50%
2. Capacity-building record - 50%
The deadline for nominations is the 11th of November 2021. Late nominations will not be considered.
Please send your inquiries, nominations, and supporting letters to Prof Zaheer Baber, Editor-in-Chief, Journal of Pharmaceutical Policy and Practice by email at Z.Babar@hud.ac.uk
Kind Regards
Professor Zaheer-Ud-Din Babar BPharm MPharm PhD SFHEA
Professor in Medicines and Healthcare
Director, Centre for Pharmaceutical Policy and Practice Research
Department of Pharmacy, University of Huddersfield, UK
Editor-in-Chief
Journal of Pharmaceutical Policy and Practice
https://joppp.biomedcentral.com/
Zaheer Babar <Z.Babar@hud.ac.uk>